CLSI eNews - 1 July 2007  (Plain Text Version)

Return to Graphical Version | Search back issues | Print all articles

In this issue:
Note on printing single articles: Each selected individual article will appear at the bottom of this screen...please scroll down to view/print the selected article.
 
News
 Executive Vice President's Message
 Volunteer Focus
 Seeking Editorial Review Board Representative for Lab Tests Online
 CLSI Implements Digital Rights Management to Protect Copyright
 Quality Automated
 Press Releases
Standards Status
 Vote and Deadlines
 Recently Approved Documents
 Recently Distributed ISO Standard
 Call for Nominations
Events and Exhibits
 Upcoming Events
 Upcoming Presentations
 CLSI Meetings Calendar
Participate in CLSI
 Volunteer
 New and Sustaining Members
 Update Your Subscription


Recently Approved Documents

Enumeration of Immunologically Defined Cell Populations by Flow Cytometry (H42-A2); Principles and Procedures for Blood Cultures (M47-A)

Second Notice

H42-A2Enumeration of Immunologically Defined Cell Populations by Flow Cytometry; Approved Guideline—Second Edition
This document provides guidance for the immunophenotypic analysis of non-neoplastic lymphocytes by immunofluorescence-based flow cytometry; sample and instrument quality control; and precautions for acquisition of data from lymphocytes.
Purchase here.

M47-APrinciples and Procedures for Blood Cultures; Approved Guideline
This document provides recommendations for the collection, transport, and processing of blood cultures as well as guidance for the recovery of pathogens from blood specimens taken from patients who are suspected of having bacteremia or fungemia.
Purchase here.


Our procedures have been designed to ensure that consensus has been achieved when a standard or guideline is published at the approved level. This means that a document has been rigorously reviewed by the authoring subcommittee, the area committee overseeing the project, the Board of Directors, and the medical-testing community that participates in the consensus process by carefully reviewing and commenting on the standard or guideline.

You may automatically receive or select approved-level documents as a member benefit.  Find out more about joining CLSI:  view membership options and benefits.


For more information or to contact us directly, please visit www.clsi.org l ©2006 Clinical and Laboratory Standards Institute